Published in Ann Rheum Dis on July 01, 1991
Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med (1990) 7.49
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet (1989) 3.39
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum (1984) 3.33
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
Radiographic changes in early rheumatoid disease. Ann Rheum Dis (1977) 2.66
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med (1974) 2.47
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum (1988) 2.41
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Do drugs change the course of rheumatoid arthritis? Br Med J (1980) 1.69
A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months. Arthritis Rheum (1988) 1.60
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment. Clin Rheumatol (1988) 1.58
Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis (1981) 1.55
The cycling of combination antirheumatic drug therapy in rheumatoid arthritis. Br J Rheumatol (1990) 1.41
Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. JAMA (1986) 1.41
Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) (1986) 1.35
Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol (1977) 1.35
Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis. Br J Rheumatol (1987) 1.29
Chrysotherapy. A prospective study. Arthritis Rheum (1977) 1.27
Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis (1987) 1.21
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun (1989) 1.11
Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol (1983) 1.10
Rheumatoid arthritis: disease-modifying antirheumatic drugs. Clin Rheum Dis (1983) 1.08
Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole. J Rheumatol (1981) 1.07
Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. JAMA (1982) 1.04
Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum (1987) 0.98
Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum (1984) 0.95
Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study. Br J Rheumatol (1987) 0.88
Clinical trials. A guide to understanding methodology and interpreting results. Arthritis Rheum (1990) 0.88
Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. Scand J Rheumatol (1987) 0.86
Second course gold therapy in the treatment of rheumatoid arthritis. Arthritis Rheum (1983) 0.86
Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis. Clin Rheumatol (1986) 0.86
Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. Ann Rheum Dis (1989) 0.86
Reforming the pyramid. A plan for treating rheumatoid arthritis in the 1990s. Rheum Dis Clin North Am (1989) 0.84
Pulse steroid therapy and the search for improved drug therapy of rheumatoid arthritis. J Rheumatol (1988) 0.84
Intra-articular orgotein in osteoarthritis of the knee: a placebo-controlled efficacy, safety, and dosage comparison. Am J Med (1989) 0.82
[Clinical testing of intra-articularly injected glycosaminoglycan polysulfate in gonarthrosis ( a controlled multicenter double-blind study)]. Z Orthop Ihre Grenzgeb (1983) 0.82
Mechanism of action of non-steroidal anti-rheumatic drugs. Baillieres Clin Rheumatol (1988) 0.79
Long-term studies of antiosteoarthritic drugs: an assessment. Semin Arthritis Rheum (1987) 0.78
Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model. Arthritis Rheum (1989) 0.78
Prolonged improvement in refractory rheumatoid arthritis after antithymocyte globulin therapy of brief duration. Arthritis Rheum (1989) 0.77
Combination therapy in rheumatoid arthritis. Baillieres Clin Rheumatol (1990) 0.76
Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Clin Rheum Dis (1984) 0.76
Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study. Clin Exp Rheumatol (1987) 0.76
Heroic treatment for nonmalignant disease. JAMA (1982) 0.76
A double-blind controlled trial of Rumalon in the treatment of painful osteoarthrosis of the hip. Ann Rheum Dis (1970) 0.76
Specificity of lumbar medial branch and L5 dorsal ramus blocks. A computed tomography study. Spine (Phila Pa 1976) (1997) 0.99
Combination therapy in rheumatoid arthritis. Baillieres Clin Rheumatol (1990) 0.76